These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
725 related articles for article (PubMed ID: 11299771)
1. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. Yin F; Giuliano AE; Law RE; Van Herle AJ Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771 [TBL] [Abstract][Full Text] [Related]
2. Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Wang W; Heideman L; Chung CS; Pelling JC; Koehler KJ; Birt DF Mol Carcinog; 2000 Jun; 28(2):102-10. PubMed ID: 10900467 [TBL] [Abstract][Full Text] [Related]
3. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031 [TBL] [Abstract][Full Text] [Related]
4. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
5. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells. Zhu WY; Jones CS; Kiss A; Matsukuma K; Amin S; De Luca LM Exp Cell Res; 1997 Aug; 234(2):293-9. PubMed ID: 9260897 [TBL] [Abstract][Full Text] [Related]
6. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity. Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019 [TBL] [Abstract][Full Text] [Related]
7. Analysis of cell growth inhibitory effects of catechin through MAPK in human breast cancer cell line T47D. Deguchi H; Fujii T; Nakagawa S; Koga T; Shirouzu K Int J Oncol; 2002 Dec; 21(6):1301-5. PubMed ID: 12429981 [TBL] [Abstract][Full Text] [Related]
8. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells. Zi X; Grasso AW; Kung HJ; Agarwal R Cancer Res; 1998 May; 58(9):1920-9. PubMed ID: 9581834 [TBL] [Abstract][Full Text] [Related]
9. Daidzein causes cell cycle arrest at the G1 and G2/M phases in human breast cancer MCF-7 and MDA-MB-453 cells. Choi EJ; Kim GH Phytomedicine; 2008 Sep; 15(9):683-90. PubMed ID: 18541420 [TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein-2 blocks MDA MB 231 human breast cancer cell proliferation by inhibiting cyclin-dependent kinase-mediated retinoblastoma protein phosphorylation. Ghosh-Choudhury N; Woodruff K; Qi W; Celeste A; Abboud SL; Ghosh Choudhury G Biochem Biophys Res Commun; 2000 Jun; 272(3):705-11. PubMed ID: 10860819 [TBL] [Abstract][Full Text] [Related]
11. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases. Touyz RM; Yao G J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962 [TBL] [Abstract][Full Text] [Related]
12. A polyphenolic fraction from grape seeds causes irreversible growth inhibition of breast carcinoma MDA-MB468 cells by inhibiting mitogen-activated protein kinases activation and inducing G1 arrest and differentiation. Agarwal C; Sharma Y; Zhao J; Agarwal R Clin Cancer Res; 2000 Jul; 6(7):2921-30. PubMed ID: 10914742 [TBL] [Abstract][Full Text] [Related]
13. Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins. Zi X; Feyes DK; Agarwal R Clin Cancer Res; 1998 Apr; 4(4):1055-64. PubMed ID: 9563902 [TBL] [Abstract][Full Text] [Related]
14. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Bacus SS; Gudkov AV; Lowe M; Lyass L; Yung Y; Komarov AP; Keyomarsi K; Yarden Y; Seger R Oncogene; 2001 Jan; 20(2):147-55. PubMed ID: 11313944 [TBL] [Abstract][Full Text] [Related]
15. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells. Hsu YL; Kuo PL; Lin LT; Lin CC J Pharmacol Exp Ther; 2005 Apr; 313(1):333-44. PubMed ID: 15626723 [TBL] [Abstract][Full Text] [Related]
16. Physalis angulata induced G2/M phase arrest in human breast cancer cells. Hsieh WT; Huang KY; Lin HY; Chung JG Food Chem Toxicol; 2006 Jul; 44(7):974-83. PubMed ID: 16427178 [TBL] [Abstract][Full Text] [Related]
17. Apigenin causes G(2)/M arrest associated with the modulation of p21(Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells. Choi EJ; Kim GH J Nutr Biochem; 2009 Apr; 20(4):285-90. PubMed ID: 18656338 [TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway. Kim EJ; Park KS; Chung SY; Sheen YY; Moon DC; Song YS; Kim KS; Song S; Yun YP; Lee MK; Oh KW; Yoon DY; Hong JT J Pharmacol Exp Ther; 2003 Nov; 307(2):505-17. PubMed ID: 12966153 [TBL] [Abstract][Full Text] [Related]
19. Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53. Vikhanskaya F; Erba E; D'Incalci M; Broggini M Exp Cell Res; 1996 Sep; 227(2):380-5. PubMed ID: 8831577 [TBL] [Abstract][Full Text] [Related]
20. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1. Hu M; Wang J; Chen P; Reilly RM Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]